Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Suvorexant for Insomnia in Bipolar Disorder
NCT02527564Phase 4Completed
- Sponsor
- Stanford University
- Start
- Sep 2015
- Primary completion
- Mar 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of suvorexant in Insomnia, sponsored by Stanford University. Started Sep 2015; status: completed.
02
Drugs
suvorexant
03
Conditions
Insomnia
Beyond the preview
Go deeper on NCT02527564.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02527564.